PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Centre Georges-François Leclerc, 1 rue Pr Marion, 21079, Dijon Cedex, France.\', \'INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.\', \'Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189, Nice cedex 2, France.\', \'Groupe de Pharmacologie Clinique & Oncologique (GPCO)-Unicancer, 101 rue de Tolbiac, 75013, Paris, France.\', \'ICR, IUCT-Oncopole, Toulouse, France.\', \'Université de Toulouse, CRCT, Inserm UMR1037, 31000, Toulouse, France.\', \'Service Oncologie Médicale, CHU Jean-Minjoz, 3, boulevard Alexandre-Fleming, 25030, Besançon, France.\', \'Laboratoire de Pharmacologie Clinique, CHU Jean-Minjoz, 3, boulevard Alexandre-Fleming, 25030, Besançon, France.\', \'INSERM, EFS BFC, UMR1098, Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire Et Génique, Université Bourgogne Franche-Comté, 25000, Besançon, France.\', \'Pharmacy Department, Centre Georges-François Leclerc, 1 rue Pr Marion, 21079, Dijon Cedex, France. antonin.schmitt@u-bourgogne.fr.\', \'INSERM U1231, University of Burgundy Franche-Comté, Dijon, France. antonin.schmitt@u-bourgogne.fr.\', \'Groupe de Pharmacologie Clinique & Oncologique (GPCO)-Unicancer, 101 rue de Tolbiac, 75013, Paris, France. antonin.schmitt@u-bourgogne.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00280-020-04208-8
?:doi
?:hasPublicationType
?:journal
  • Cancer chemotherapy and pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33386926
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.147
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33386926>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33386926>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all